SCHEMBL2637371

SCHEMBL2637371

OC(c1c(Cl)ccc(Br)c1Cl)c1c[nH]c2ncccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 1/20 0.48
▸ DYRK1B Q9Y463 2/20 0.39
▸ RPS6KA5 O75582 1/20 0.38
▸ GRM8 O00222 1/20 0.38
▸ GRM4 Q14833 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ GPR84 Q9NQS5 1/20 0.38
▸ CDC7 O00311 4/20 0.36
▸ DAPK3 O43293 3/20 0.36
▸ MAP4K4 O95819 3/20 0.36
▸ PIM1 P11309 3/20 0.36
▸ PRKACA P17612 3/20 0.36
▸ CLK2 P49760 3/20 0.36
▸ GSK3B P49841 3/20 0.36
▸ CDK7 P50613 3/20 0.36
▸ CDK9 P50750 3/20 0.36
▸ PRKX P51817 3/20 0.36
▸ CDK5 Q00535 3/20 0.36
▸ DYRK1A Q13627 3/20 0.36
▸ CLK4 Q9HAZ1 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2637232 0.82 AXL (0.45) AXLDYRK1BRPS6KA5GRM8GRM4
SCHEMBL19471801 0.76 CCNB2 (0.40) AXLDYRK1BRPS6KA5GRM8GRM4
SCHEMBL858184 0.76 AXL (0.48) AXLDYRK1BRPS6KA5GRM8GRM4
SCHEMBL17435055 0.74 AXL (0.37) AXLDYRK1BRPS6KA5GRM8GRM4
SCHEMBL858300 0.74 AXL (0.44) AXLDYRK1BRPS6KA5GRM8GRM4
SCHEMBL857039 0.72 MAPT (0.49) AXLGRM8GRM4MAPTGPR84
SCHEMBL21872984 0.71 CDC7 (0.41) AXLDYRK1BRPS6KA5GRM8GRM4
SCHEMBL1267952 0.71 AXL (0.48) AXLGRM8GRM4MAPTGPR84
SCHEMBL1359136 0.71 MET (0.43) MAP4K4CLK2CDK5DYRK1ACLK4
SCHEMBL1358648 0.70 ITK (0.46) MAPTMAP4K4CLK2CDK5DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2569314-A1 FUSED BICYCLIC KINASE INHIBITORS OSI Pharmaceuticals, LLC (US) 2013-03-20 — — EP disclosed
WO-2011143645-A1 FUSED BICYCLIC KINASE INHIBITORS OSI Pharmaceuticals, LLC (US) 2011-11-17 — — WO disclosed
Send feedback